Emmessar Biotech & Nutrition MD, chairman, board of directors and AGM
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹22.32.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹11 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Aug 2026
- 26.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Aug 2026
- −18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,899
Statutory auditor
Named in the results for the quarter to Mar 2026.
- V. NAGARAJAN & COPeer-review certificate valid to Aug 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Emmessar Biotech & Nutrition AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Emmessar Biotech & Nutrition share news and announcements
Annual general meeting, 29 Sep 2026
7,197 shareholders on the register on 22 Sep 2026; present: 4 promoters and 28 others; votes counted by Tribhuwneshwar Kaushik / Kaushik Joshi & Co..The company's voting result (opens in a new tab)
- Adoption of financial statements for the year ended March 31, 2026Ordinary95.31% for4.69% against
Against: promoters 0.00% · institutions 0.00% · other public 74.98%
Turnout: all 33.50% · promoters 52.76% · institutions 0.00% · other public 5.21%
To appoint Mr. Jeyavel Balaiah Nadar (DIN: 08163899), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment as Director and in this regard to pass the following resolution as an Ordinary ResolutionMoreLess
Ordinary95.31% for4.69% againstAgainst: promoters 0.00% · institutions 0.00% · other public 74.98%
Turnout: all 33.50% · promoters 52.76% · institutions 0.00% · other public 5.21%
- Re-appointment of Mr. Srinivasa Raghavan Mathurakavi Ayyangar, Managing Director (DIN: 00090266) of the Company for a further period of 5 yearsSpecialPromoters have an interest in it95.31% for4.69% against
Against: promoters 0.00% · institutions 0.00% · other public 74.98%
Turnout: all 33.50% · promoters 52.76% · institutions 0.00% · other public 5.21%
- Re-appointment of Mr. Jeyavel Balaiah Nadar, Whole time Director (DIN: 08163899) of the Company for a further period of 5 yearsSpecial95.31% for4.69% against
Against: promoters 0.00% · institutions 0.00% · other public 74.98%
Turnout: all 33.50% · promoters 52.76% · institutions 0.00% · other public 5.21%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.